Showing results (1451-1460 of 2,482) with videos related to

Sort By:
Pageof 249
Clinical and Translational Science|January 19, 2023
Physiologically-based pharmacokinetic model to investigate the effect of pregnancy on risperidone and paliperidone pharmacokinetics: Application to a pregnant woman and her neonateWalaa Y B Mahdy, Kazuhiro Yamamoto, Takahiro Ito, et al.
Clinical and Translational Science|December 24, 2022
Effect of discontinuation of lemborexant following long-term treatment of insomnia disorder: Secondary analysis of a randomized clinical trialYoshikazu Takaesu, Masahiro Suzuki, Margaret Moline, et al.
Clinical and Translational Science|July 1, 2022
Longitudinal nonlinear mixed effects modeling of EGFR mutations in ctDNA as predictor of disease progression in treatment of EGFR-mutant non-small cell lung cancerJulie M Janssen, Remy B Verheijen, Tirsa T van Duijl, et al.
Clinical and Translational Science|January 6, 2021
Hybrid physiologically-based pharmacokinetic model for remdesivir: Application to SARS-CoV-2James M Gallo
Clinical and Translational Science|June 22, 2021
Safety, tolerability, and pharmacokinetics of oral baicalein tablets in healthy Chinese subjects: A single-center, randomized, double-blind, placebo-controlled multiple-ascending-dose studyLijun Li, Hongzhi Gao, Kun Lou, et al.
Clinical and Translational Science|June 26, 2021
Evaluation of moxifloxacin in canine and non-human primate telemetry assays: Comparison of QTc interval prolongation by timepoint and concentration-QTc analysisRay W Chui, Joel Baublits, Fiona A Chandra, et al.
Clinical and Translational Science|June 19, 2021
Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel diseaseDebora Curci, Marianna Lucafò, Adriana Cifù, et al.
Clinical and Translational Science|June 14, 2021
Evaluation of population-level pharmacogenetic actionability in AlabamaBrittney H Davis, Kelly Williams, Devin Absher, et al.
Clinical and Translational Science|June 14, 2021
Pharmacokinetics of daridorexant, a dual orexin receptor antagonist, are not affected by renal impairmentBenjamin Berger, Clemens Muehlan, Gernot Klein, et al.
Clinical and Translational Science|May 22, 2022
Associations of HLA genetic variants with carbamazepine-induced cutaneous adverse drug reactions: An updated meta-analysisMohitosh Biswas, Maliheh Ershadian, John Shobana, et al.
Pageof 249